Adial Pharmaceuticals Inc (ADIL)

Currency in USD
0.380
-0.007(-1.81%)
Closed·
After Hours
0.370-0.010(-2.58%)
·
ADIL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ADIL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3670.397
52 wk Range
0.2201.300
Key Statistics
Prev. Close
0.387
Open
0.38
Day's Range
0.367-0.397
52 wk Range
0.22-1.3
Volume
1.05M
Average Volume (3m)
8.97M
1-Year Change
-61.22%
Book Value / Share
0.32
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADIL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.000
Upside
+952.63%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Adial Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Adial Pharmaceuticals Inc Company Profile

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company’s lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.

Compare ADIL to Peers and Sector

Metrics to compare
ADIL
Peers
Sector
Relationship
P/E Ratio
−0.7x−0.4x−0.5x
PEG Ratio
−0.010.030.00
Price/Book
2.8x2.0x2.6x
Price / LTM Sales
-1.6x3.3x
Upside (Analyst Target)
-230.5%43.5%
Fair Value Upside
Unlock5.6%6.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.000
(+952.63% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.34 / -0.39
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ADIL Income Statement

People Also Watch

2.070
VOR
0.00%
51.43
BMNR
+24.59%
18.23
SRPT
+1.50%
2.56
INMB
-8.24%
5.670
GVH
+9.88%

FAQ

What Stock Exchange Does Adial Pharma Trade On?

Adial Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Adial Pharma?

The stock symbol for Adial Pharma is "ADIL."

What Is the Adial Pharma Market Cap?

As of today, Adial Pharma market cap is 5.99M.

What Is Adial Pharma's Earnings Per Share (TTM)?

The Adial Pharma EPS (TTM) is -1.56.

From a Technical Analysis Perspective, Is ADIL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Adial Pharma Stock Split?

Adial Pharma has split 1 times.

How Many Employees Does Adial Pharma Have?

Adial Pharma has 5 employees.

What is the current trading status of Adial Pharma (ADIL)?

As of 09 Aug 2025, Adial Pharma (ADIL) is trading at a price of 0.38, with a previous close of 0.39. The stock has fluctuated within a day range of 0.37 to 0.40, while its 52-week range spans from 0.22 to 1.30.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.